Forte Biosciences (FBRX) Tax Rate (2018 - 2026)

Forte Biosciences (FBRX) posted quarterly Tax Rate of 1.71% for Q1 2026, down 119.58% quarter-over-quarter from 8.75% in Q4 2018.

Forte Biosciences (FBRX) Tax Rate (2018 - 2026) Analysis & Trends

Forte Biosciences (FBRX) has reported Tax Rate for 2 consecutive years, with 1.71% the latest figure, recorded in Q1 2026.

In Q1 2026, Tax Rate changed N/A year-over-year to 1.71%; the TTM figure through Mar 2026 stood at 1.24% (up 82.0% YoY), while the FY2025 annual figure was 1.43%, down 16434.0% from the prior year.
Tax Rate retreated to 1.71% in Q1 2026 per FBRX's latest filing, from 8.75% in the prior quarter.
Across five years, Tax Rate topped out at 1.71% in Q1 2026 and bottomed at 1.71% in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	Forte Biosciences	1.63 Bn	1.28 Bn	-	-0.83%

Download Data